Transcription of the immediate early gene BZLF1 is mediated initially through the activation of cellular transcription factors. Reporterbased studies have provided evidence that following this initial activation, the BZLF1 gene product Zta may be involved in an autoactivation loop through binding to its promoter Zp. In contrast, other reports have shown that transfection of a Zta expression vector in latently infected cells does not activate endogenous Zp. Using chromatin immunoprecipitation (ChIP) assays, we show here that Zta binds to endogenous Zp following induction of the lytic cycle by anti-Ig and TGF-beta1 and that binding occurs early enough to play a role in the activation of Zp. We have also generated a dominant-negative Zta and shown that it inhibits activation of endogenous Zp. These data support a two-step model for Zp activation during reactivation involving initial activation by cellular factors followed by an autoactivation step. D
Introduction
Following initial exposure, the Epstein-Barr virus (EBV) establishes a persistent infection and exists in a predominantly latent state for the life of the host (Kieff and Liebowitz, 1990; Miller, 1990) . Despite this predominantly latent state, EBV intermittently reactivates leading to the production of infectious virions. Although the triggers that elicit the switch from latency to lytic replication cycle in vivo are largely unknown, it is possible that changes in local cytokine environment or engagement of antigen may induce reactivation in a fraction of EBV-positive B lymphocytes. In tissue culture, these mechanisms can be modeled by treating EBV-positive B cell lines with TGF-beta1 or through cross-linking the immunoglobulin receptor with an anti-immunoglobulin antibody, respectively.
A key regulator mediating the transition from the latent to the lytic phase is the viral transactivator Zta (also called ZEBRA, BZLF1, and EB1; Countryman et al., 1987; Miller et al., 1984) . Zta, along with the viral transactivator Rta, is the first viral gene expressed after stimulation of the lytic cycle (Takada and Ono, 1989) . Further, transfection of an expression vector containing the Zta reading frame leads to induction of the entire lytic cascade resulting in viral production (Countryman et al., 1987; Miller et al., 1984) . Therefore, control of the Zta promoter Zp is a key regulatory point in the transition from latency to the lytic replication cycle.
A number of functional regulatory elements in Zp have been identified by DNase I footprint analysis (Flemington and Speck, 1990a,b) and transcription factors that bind these elements have been determined (Adamson et al., 2000; Borras et al., 1996; Kraus et al., 2001 Kraus et al., , 2003 Liu et al., 1997 Liu et al., , 1998 Ruf and Rawlins, 1995; Speck et al., 1997) (Fig. 1) . Interestingly, several elements have been shown to inhibit Zp activity in the absence of inducing signals including ZV (Kraus et al., 2001 (Kraus et al., , 2003 , ZIIR (Liu et al., 1998) , and the MEF2D binding sites (Borras et al., 1996; Flemington and Speck, 1990b; Gruffat et al., 2002) . MEF2D has also been shown to recruit histone deacetylases to Zp that presumably compacts the chromatin structure (Gruffat et al., 2002) . The standard model for Zp activation includes an initial reversal of the inhibitory effects of the negative promoter elements (perhaps in part through dissociation of HDACs) followed by the recruitment of activating factors such as histone acetylases by transcription factors bound to Zp. These changes would result in an opening of the local chromatin structure and remodeling in a way that allows transcription initiation to ensue.
Footprinting studies identified two Zta binding sites in Zp (Flemington and Speck, 1990a; Lieberman and Berk, 1990 ) and co-transfection of Zta expression vectors with Zp reporter plasmids showed that Zta can bind these two elements and activate Zp transcription (Flemington and Speck, 1990a; Urier et al., 1989) . This suggested that following the initial induction of Zp by cellular factors, newly synthesized Zta could then bind Zp and support high level expression of Zta (Flemington and Speck, 1990a) . Importantly, however, subsequent studies reported that transfection of a Zta expression vector into EBV-positive cells did not result in induction of the endogenous Zta promoter (Kolman et al., 1996; Le Roux et al., 1996) . The ability of Zta to activate a Zp reporter construct that is added to cells in a naked form (i.e., without associated chromatin proteins) but not endogenous Zp, which is presumably maintained in a compact chromatin structure, suggested that binding of Zta to Zp may be regulated in part through accessibility issues. Alternatively, Zta may bind Zp but may not have the capacity to overcome imprinted inhibitory signals at Zp. We therefore tested whether Zta binds endogenous Zp during the activation stages of Zp following treatment of EBV-positive cells with lytic cycle-inducing agents. In addition, using a dominant-negative Zta, we tested whether Zta function is required for full Zp activity under these inducing conditions.
Results

Binding of Zta to Zp following anti-Ig treatment of Akata cells
Chromatin immunoprecipitation (ChIP) analysis was used to assess the binding of Zta to Zp during reactivation. Akata cells were treated for 0, 2, or 4 h with 1 Ag/ml anti-Ig, and the cells were cross-linked with formaldehyde. Cell lysates were generated, the genomic DNA was sheared to an average size of approximately 500 bp, and the samples were subjected to immunoprecipitation with either a control or an anti-Zta antibody (Taylor et al., 1989) . The amount of Zp precipitated was determined using real-time PCR with the primers Zpleft and Zpright that give rise to a 181-bp product extending from À191 to À11 of Zp ( Fig. 1) . A correlation coefficient of 0.997 and a PCR efficiency of 100% were observed for the standard curve indicating a high degree of accuracy (Fig. 2) . The melting temperature profiles indicate the presence of only one product for all PCR reactions (Fig. 2) , and this was verified by agarose electrophoresis (data not shown). As shown in Fig. 2 , the amount of Zp precipitated by a Zta antibody in Akata cells not treated with anti-Ig was similar to the amount of Zp precipitated with a control antibody. In contrast, a significant increase in the amount of Zp was precipitated with a Zta antibody in cells treated for 2 or 4 h with anti-IgG.
To determine whether this increase is specific to Zp, ChIP analysis was carried out again and the immunoprecipitated material was used for PCR reactions with Zp primers as well as primers for the latency promoter Qp. As shown in Fig. 3 , although an increase in the amount of Zp precipitated with the Zta antibody is observed at 2, 4, and 8 h postinduction, there is little change in the amount of Qp. To establish that the DNA-shearing step was sufficient to prevent the precipitation of Zta bound to distal Zta binding sites surrounding Zp, the precipitated material was also subjected to PCR using primers for the third exon of the BZLF1 gene, which amplifies a fragment that is 857 bp downstream from the Zp transcription initiation site. No significant change in the amount of the exon 3 region of BZLF1 was seen in the Zta precipitate, suggesting that the Fig. 1 . Schematic representation of Zp. The homologous ZI elements (ZIA, ZIB, ZIC, and ZID) have been shown to bind either SP1/3 or MEF2D. The ZII domain has been shown to bind members of the ATF/CREB family. The transcription factor ZEB has been shown to bind the ZV element and a putative repressor factor has been implicated in binding adjacent to the CREB/ATF binding sequences. PCR primers used for Zp ChIP experiments are indicated.
Fig. 2.
Chromatin immunoprecipitation (ChIP) analysis of Zta binding to Zp following treatment with anti-Ig. Akata cells were treated with anti-Ig for 0, 2, or 4 h and cell lysates were subjected to immunoprecipitation with either no antibody or an anti-Zta antibody (a gift from George Miller, Yale). Real-time PCR was then carried out to quantitate the amounts of co-precipitating Zta promoter (Zp). For bar graph, results are plotted as the amount of Zp relative to the amount of Zp at 0 h with control antibody divided by the input value for each respective time point. increase in the amount of Zp precipitated with the Zta antibody is likely to represent binding of Zta to bona fide promoter sequences.
Binding of Zta to Zp in TGF-beta1-treated Mutu I cells
To test whether Zta binds Zp following cytokine-induced reactivation, ChIP analysis was carried out following treatment of Mutu I cells with TGF-beta1. Mutu I cells were cultured for 0, 4, 8, or 24 h in the presence of 5 ng/ml TGF-beta1 and processed as above. A significant increase in the amount of Zp precipitated with the anti-Zta antibody was observed at 4, 8, and 24 h post-induction ( Fig. 4) , indicating that Zta binds Zp following TGF-beta1-mediated reactivation in Mutu I cells. In contrast, no significant increase in Zta binding to Qp or to another latency promoter LMP1 was seen following induction of the lytic cycle with TGF-beta1. This supports the idea that the increase in the binding of Zta to Zp following activation of the lytic cycle with TGF-beta1 is specific to lytic-related genes.
Generation of a dominant-negative Zta
The data presented above indicate that Zta binds Zp following either anti-Ig or TGF-beta1 stimulation and that binding occurs during the activation phase of Zp. The timing of binding supports the hypothesis that Zta plays a positive role in Zp function. However, to more directly address whether Zta is required for full Zp function, we generated a truncated form of Zta that contains the Zta homodimerization domain but which should be defective for transcriptional activation as well as DNA binding with the idea that this may act as a dominant-negative form of Zta and inhibit the transcriptional activation function of wildtype Zta. As shown in Fig. 5A , the entire Zta activation domain has been deleted and serine 186, which is in the basic/DNA binding domain of Zta, was mutated to glutamic acid. Previous studies have shown that this point mutation abrogates the DNA binding properties of Zta (Baumann et al., 1998) , and we have shown previously that deletion of the activation domain results in severely impaired activation function (Flemington et al., 1992) . Importantly, although we have reported that Zta can induce cell growth arrest, we have also shown that the serine 186 to glutamic acid mutation largely abrogates Zta's growth arrest properties (Rodriguez et al., 2001) . In addition, we have also shown that deletion of the Zta activation domain abrogates Zta's ability to induce the expression of the cyclin-dependent kinase inhibitor p27 (Rodriguez et al., 1999) . We were therefore hopeful that this Zta mutant would be able to inhibit the function of wild-type Zta but would be defective for Zta's cell growth arrest activity.
Co-transfection of the EBV-positive cell line NPC-KT with wild-type Zta and either a control (pMSCV) or the Zdn expression vector (pMSCV-Zdn) shows that Zdn inhibits the ability of Zta to activate expression of the Zta-responsive Fig. 3 . Binding of Zta to Zp following induction of the lytic cycle with anti-Ig. Akata cells were treated with anti-Ig for 0, 2, 4, or 8 h and cell lysates were subjected to immunoprecipitation with either a control or an anti-Zta antibody. Real-time PCR was then carried out to quantitate the amounts of the Zta promoter (Zp), the group I latency promoter (Qp), or the third exon of the BZLF1 gene (Exon 3). Data are plotted against control antibody at 0 h. Standard deviation was used to calculate error. BMRF1 promoter (Fig. 5B ). We have also generated stable NPC-KT lines carrying either pMSCV or pMSCV-Zdn and found that (1) approximately equal numbers of colonies were observed in both pMSCV-and pMSCV-Zdn-transfected cultures, and (2) that pMSCV-Zdn clones grow at approximately the same rate as pMSCV colonies (data not shown). Together, these data support the idea that Zdn can be used to address whether Zta is required for activation of Zp during anti-Ig-or TGF-beta1-mediated reactivation.
Inhibition of endogenous Zta expression by Zdn
To address whether Zdn inhibits anti-Ig-or TGF-beta1mediated activation of Zp, we utilized Mutu I cells for the following reasons. First, Mutu I cells are responsive to both TGF-beta1 and anti-IgM. Second, in our hands, we have been able to obtain close to 100% infection efficiencies through retroviral transduction (data not shown). In contrast, we typically obtain approximately 20-30% transduction efficiencies in Akata cells. We felt this was important because we wanted to carry out induction experiments in cells that had not been subjected to prolonged antibiotic selection that could select for subcultures of cells with distinct phenotypes. Mutu I cells were therefore infected with either pMSCV or pMSCV-Zdn retrovirus and incubated for 2 days before the addition of puromycin (Fig. 6) . Infected cells were cultured for 5 days in the presence of puromycin before they were treated with either anti-IgM, TGF-beta1, or tricostatin A (TSA). During the puromycin selection process, little cell death was observed in the infectants whereas uninfected Mutu I cells are completely nonviable within 3 days of culture in puromycin. In addition, no difference in growth rate was observed between pMSCV-and pMSCV-Zdn-infected cells even after prolonged culturing (i.e., 3 weeks, data not shown).
As shown in Fig. 6 , Zdn inhibits the expression of BMRF1 in Mutu I cells following either anti-IgM, TGF-beta1, or TSA treatment indicating the presence of functional Zdn. Analysis of endogenous Zta expression indicated that indeed, Zdn inhibits (but does not completely block) the function of Zp following either of these treatments (Fig. 6 ). Expression of Rta was similarly inhibited by Zdn, indicating that Zta likely plays a role in the full activation of the Rta promoter Rp during these reactivation conditions. Analysis of the phosphorylation status of the MAP kinase ERK1/2 indicated that signaling is not grossly impaired in Zdn-infected cells (Fig. 6) , suggesting that inhibition of Zp function is indeed due to inhibition of endogenous Zta function.
Discussion
The data presented here show that Zta binds to its own promoter following reactivation of the lytic cycle with two inducing agents that may mimic physiological signaling, anti-Ig, and TGF-beta1. The binding of Zta to Zp using ChIP analysis following anti-Ig treatment of Akata cells has recently been reported (Wu et al., 2004) . However, this Fig. 4 . Binding of Zta to Zp following induction of the lytic cycle with TGF-beta1. Mutu I cells were treated with TGF-beta1 for 0, 4, 8, or 24 h, and cell lysates were subjected to immunoprecipitation with either a control or an anti-Zta antibody. Real-time PCR was then carried out to quantitate the amounts of the Zta promoter (Zp), the group I latency promoter (Qp), or the promoter for the latency membrane protein LMP1 (LMP1p). Data are plotted against control antibody at 0 h. Standard deviation was used to calculate error. study was carried out at 40 h post-induction, which is well past the point of maximal Zta expression in Akata cells, which occurs at approximately 4-6 h post-induction (Flemington et al., 1991; Takada and Ono, 1989) . Our studies show that binding of Zta to Zp occurs specifically during the activation stages of Zp, therefore demonstrating that the binding of Zta to Zp is temporally consistent with Zta playing a positive role in the activation of Zp during anti-Ig-and TGF-beta1-induced reactivation. In addition, we have generated a dominant-negative form of Zta (Zdn) and have shown that Zdn inhibits induction of Zta. Together, these data strongly support a role for Zta in regulating its own promoter during reactivation.
It is notable that in Zdn-infected cells, there is still some degree of activation of endogenous Zta expression. This is consistent with the idea that cellular factors play an initial role in activation of Zp. Nevertheless, it is also reasonable to assume that Zdn is not 100% effective in inhibition of endogenous Zta function. Therefore, based on our current data, we cannot make conclusions as to the relative contribution of autoactivation vs. initial induction by cellular factors. But it is clear that Zdn significantly inhibits Zp function and therefore our data support the two-step model for activation involving initial activation through cellular transcription factors followed by a commitment step that is enforced by an autoactivation mechanism.
How can our data be reconciled with previous studies showing that ectopic expression of Zta in EBV-positive cell lines does not induce endogenous Zp? It is possible that during latency, Zp exists in a compacted chromatin 6 . Analysis of Zta expression in MutuI cells infected with either pMSCV-puro or pMSCV-puro-Zdn. Cells were infected as described in Materials and methods and selected for 5 days in the presence of puromycin. Cultures were then induced as described in Materials and methods and assayed by Western blot analysis using antibodies against Zta (Argene, Cat# 11-007), BMRF1 (Capricorn, EBV12900), and Actin (Sigma, Cat#A4700), Rta (Argene, 11-008), and phosphorylated ERK1/2 (Cell Signaling, Cat#9106). configuration that precludes binding of Zta and that initial signaling events mediated by anti-Ig or TGF-beta1 lead to an opening of the local chromatin to allow Zta to bind. This is a reasonable hypothesis however there are two previous observations suggesting that other more complex possibilities should be considered. Deng et al. (2003) showed that ectopic Zta can bind to Zp in latently infected cells and Jenkins et al. (2000) have shown that there is no gross alteration in nucleosome phasing at Zp following induction. While there may be trivial explanations for these latter observations, it is also possible that Zta may be able to bind Zp during either the latent or the reactivated state but that in the absence of other signaling events mediated by TGF-beta1 or anti-Ig, Zta is not capable by itself to overcome some key imprinted obstacle to transcriptional activation of endogenous Zp. Regardless of the mechanistic details involved in this process, the idea that Zta cannot induce Zp during latency but can induce Zp during reactivation conditions suggests that EBV has evolved with a mechanism to help suppress spurious entry into the lytic cycle unless bona fide reactivation signaling is detected (Fig. 7) . In this case, some degree of leakiness of Zp could be tolerated during latency, but such low levels of spurious Zta would not lead to commitment to full Zp function through the autoactivation loop. However, during the appropriate conditions (e.g., following TGF-beta1 signaling or B cell receptor engagement), low levels of Zta would be fully capable of autoactivation and would lead to a commitment to high level Zta expression and commitment to entry into the complete lytic cascade.
In anti-Ig-treated Akata cells, there is a significant and reproducible increase in Zta binding at 2 h post-induction that coincides with a relatively moderate increase in the level of Zta observed by Western blot analysis (see Figs. 2 and 3) . This is consistent with previous studies where nuclear extracts prepared from anti-Ig-treated Akata cells contained a significant level of Zta DNA binding activity (in vitro) as early as 1 h post-induction and this binding activity was approximately equal to the level of Zta DNA binding activity observed in extracts prepared at 3 h post-induction (Bryant and Farrell, 2002) . These in vitro binding studies were carried out using one of the Zta binding sites from the Zta promoter, ZIIIB. These data together with our data indicate that in anti-Ig-treated Akata cells, Zta that is produced at the initial stages of induction may be modified (perhaps through anti-Ig-mediated signaling) in a manner that engenders it with a high DNA binding affinity (at least to binding sites within Zp). This idea is consistent with an autoactivation model because such a model requires that Zta plays a role in the ramping up of Zta expression and not necessarily after high levels of Zta have already been produced.
We have also observed that Zdn inhibits the expression of Rta whose promoter Rp has been shown in reporter assays to be responsive to Zta. Our studies provide evidence that indeed, Zta may play an important role in endogenous Rp function during reactivation. It should also be pointed out that Rp-initiated transcripts can generate a bicistronic message containing the Zta open reading frame. We considered the possibility that because Zdn inhibits Ztamediated induction of Rp, inhibition of Zta expression by Zdn may result indirectly through inhibition of Rp. However, Le Roux et al. (1996) have shown that while Rta is translated from the bicistronic Rp-initiated message, Zta is not. This argues that inhibition of Zta expression is specifically due to a direct effect on Zp-initiated transcripts from which Zta is efficiently translated.
Materials and methods
Cell culture
Akata and Mutu I cells were grown in RPMI 1640 (Life Technologies) supplemented with 10% fetal bovine serum (Life Technologies), penicillin, and streptomycin. NPC-KT and 293 cells were maintained in Dulbecco's modified Eagles medium (DMEM, Life Technologies) supplemented with 10% fetal bovine serum, penicillin, and streptomycin. All cells were grown at 37 8C in a humidified 5% CO 2containing atmosphere.
Transfections
Transfections were performed using a modified version of the calcium phosphate precipitation procedure (detailed protocol available at www.flemingtonlab.com). Briefly, 2-5 Â 10 5 cells were plated onto 100-mm diameter tissue culture dishes. The following day, the medium was replaced with 8 ml of fresh supplemented DMEM. Four to six hours later, DNA precipitates were generated by mixing 0.5 ml of 1Â HEPES-buffered saline [0.5% HEPES, 0.8% NaCl, 0.1% dextrose, 0.01% anhydrous Na 2 HPO 4 , 0.37% KCl, pH7.10] with a total of 30 Ag of plasmid DNA followed by the addition of 30 Al of 2.5 M CaCl 2 . Precipitates were allowed to form at room temperature for 20 min before adding dropwise to cells. Cells were incubated at 37 8C with 5% CO 2 for 16 h before the media were replaced with 10 ml of fresh DMEM (+10% FBS).
Lytic cycle induction
Mutu I or Akata cells were grown to near saturation and the day before induction, a 50% volume of fresh RPMI (+10% FBS, pen/strep) was added. The next day, cells were spun down and resuspended in an equal volume of freshwarmed RPMI (+10% FBS, pen/strep) containing either 10 Ag/ml anti-IgG (Sigma, Cat#I5260), 10 Ag/ml anti-IgM (Sigma, Cat#I0759), 5 ng/ml TGF-beta1 (R&D Systems, Cat#100B), or 100 ng/ml TSA (WAKO Bioproducts, Cat#200-11993). Cells were harvested at appropriate time points and subjected to either ChIP analysis or Western blot analysis.
Retroviral transduction
293 cells were transfected with 10 Ag of either pMSCVpuro or pMSCV-puro-Zdn plus 10 Ag each of the packaging plasmids, pVSV-G and pvPACK-GPdI (packaging vectors were a kind gift of Dr. Brian Schaefer). The next day, the media were replaced with 10 ml of fresh DME (+10%FBS, pen/strep). The following day, the media were taken off and subjected to two sequential centrifugations to get rid of residual 293 cells. Mutu I cells were spun down and resuspended in an equal volume of supplemented DME plus 16 Ag/ml polybrene and 1 ml was added to each well of a 6-well plate. Viral supernatant (1 ml) was added to each well and plates were spun for 1 h at 1000 Â g. The plates were then transferred to a 37 8C, 5% CO 2 incubator. Four hours later, cells for like infections were pooled, centrifuged, and resuspended in an equal volume of supplemented RPMI. Two days later, puromycin was added at 1 Ag/ml and cultured for 5 days before analysis.
ChIP analysis
ChIP studies were carried out as described previously (Wang et al., 2003) . A polyclonal anti-Zta antibody (10 Al; Taylor et al., 1989) was used for each precipitation reaction. PCR was carried out using the following primers. Zp: Zpleft 5V-TTGACACCAGCTTATTTTAGACACTTCT -3V and Zpright 5V-TTACCTGTCTAACATCTCCCCTT-TAAA-3V [which gives rise to a 181-bp product extending from 103 205 to 103 385 of the B95-8 sequence (À191 to À11 of Zp)], Z exon 3: Zex3left: 5V-CTGCTGCCAAAT-CATCTGAA-3V (102 318-102 337) and Zex3right: 5V-CA AAGAGAGCCGACAGGAAG-3V (102 128-102 147), Qp: Qpleft: 5V-AAATTGGGTGACCACTGAGG-3V (62 327-6 2 346) and Qpright (62 522-62 541), and LMPp: LMP1pleft: 5V-CCGACCCTTAGCCCTCTTAG-3V (169 953-169 972) and LMP1pright: 5V-CAAGTGCAACAGG AAATGGA-3V (169 749-169 768). PCR reactions were carried out using iCycler iQ Real-Time Detection System (Bio-Rad) with Syber Green. Fig. 7 . Proposed model for regulation of Zp by Zta. In the absence of lytic cycle-inducing signals, suppressor factors such as MEF2D, ZIIR, or ZEB play a role in compacting the local chromatin structure to prevent binding of spuriously expressed Zta or inhibit the activation function of Zta. Induction of the lytic cycle results in displacement of HDACs and the recruitment of HAT enzymes (co-activators). This leads to initial expression of Zta and opening of the chromatin structure or function. This model predicts that the relaxed chromatin structure allows for the binding or function of newly expressed Zta and a resulting high level of Zp activity and commitment to initiation of the lytic cycle.
Western blot analysis
After a single 1Â PBS wash, cells were immediately suspended in 300 Al sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer [125 mM Tris (pH 6.80), 10% glycerol, 2% SDS, 5% 2-mercaptoethanol, 0.05% bromphenol blue] and boiled for 20 min to shear the genomic DNA. Whole-cell extracts were measured with the Bio-Rad protein assay kit according to the manufacturer's instructions. Equal weight of cell lysates were subjected to SDS-PAGE electrophoresis and transferred to nitrocellulose membranes. The blots were blocked for 30 min in Tris-buffered saline containing 5% low-fat powdered milk and 1% fetal bovine serum, and then incubated with the primary antibody (in blocking buffer) overnight 4 8C. The blots were washed, incubated with secondary antibody for 1 h, washed again, and analyzed by enhanced chemiluminescence.
Plasmid construction
The Zta cDNA fragment encoding amino acids 197-245 of Zta was excised from pCMV-Zta using PstI and EcoRI. Amino acids 176-196 plus the Zta Met initiation codon were reconstituted by synthesizing the following two adaptors: ZdnAdap1, sense 5V-GATCTGCTGAAGATGATGGAAAT AAAGCGATACAAGAATCGGGTG-3V, antisense 5V-TCT TGTATCGCTTTATTTCCATCATCTTCAGCA-3V and Zdn Adap2, sense 5V-GCTGAGAGAAAATGCCGGGCCAAG TTTAAGCAACTGCTGCA-3V, antisense 5V-GCAGTTGC TTAAACTTGGCCCGGCATTTTCTCTCAGCCACCC-GAT-3V. The sense and antisense strands of ZdnAdap1 and ZdnAdap2 were annealed separately and were then added to a ligation reaction containing the PstI/EcoRI Zta fragment plus BglII-and EcoRI-digested pMSCV-puro. Positive clones were verified by sequencing to ensure that there were no oligonucleotide synthesis errors.
